All conditions

Coeliac Disease

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

375
Trials on record
48
Recruiting now
2
Australian sites
0
Phase 3 trials
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Coeliac Disease →

Get alerts when Coeliac Disease trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Coeliac Disease

Coeliac disease is a condition where the immune system reacts abnormally to gluten, a protein found in wheat, barley, rye, and oats. When someone with coeliac disease eats gluten, their immune system attacks the lining of the small intestine. Over time, this damages tiny finger-like projections called villi, which are responsible for absorbing nutrients from food. This can lead to a range of symptoms including digestive discomfort, fatigue, anaemia, and nutrient deficiencies, though some people have very few obvious symptoms at all.

Coeliac disease is more common in Australia than many people realise. Research suggests that around one in 70 Australians has the condition, making it one of the more prevalent autoimmune conditions in the country. However, it is estimated that a large proportion of people who have it remain undiagnosed. It can affect people of any age, from young children through to older adults, and tends to run in families, meaning first-degree relatives of someone with coeliac disease have a higher chance of having it themselves.

At present, the standard approach to managing coeliac disease centres on following a strict gluten-free diet for life. This means carefully avoiding foods and drinks that contain gluten, as even small amounts can cause ongoing damage to the intestine. Many people work with a gastroenterologist and an accredited dietitian to understand how to manage the diet safely and maintain good nutrition. Coeliac Australia is a national organisation that provides resources and support for people living with the condition.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Coeliac Disease in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

Research pipeline

Where trials for Coeliac Disease currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Coeliac Disease.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Coeliac Disease by country. Australia is highlighted.

Showing the top 10 of 18 countries with trial sites.

Clinical trials for Coeliac Disease

Showing 50 of 50 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT01661933 · The Prince Charles Hospital Phase 2 · 1 country Completed
Completed Phase 2 Est. completion 1 March 2014
🇦🇺 AU

Who might be able to join this trial: - You are an adult who previously took part in a related study where you were given an experimental hookworm infection, and you also have celiac disease that is being managed through your diet. Who may not be able to join: - You are currently taking medications or receiving treatm...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06982963 · Forte Biosciences, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 28 February 2027
🇦🇺 AU

**Who might be able to join this trial:** - You are a man or woman between 18 and 70 years old at the time of screening - You have been officially diagnosed with celiac disease, confirmed by an intestinal biopsy and a positive blood test for celiac disease, at least 12 months before the start of the study (the biopsy a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07239336 · Chugai Pharmaceutical Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 15 June 2027
🇦🇺 AU🇳🇿 NZ🇺🇸 US

Who might be able to join this trial: - Your body mass index (BMI) must be between 18 and 40 at the time of your screening appointment. - You must be willing to eat a gluten-free product and specially prepared products that simulate accidental gluten exposure as part of the study. - You must have been formally diagnose...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05574010 · Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA Phase 2 · 3 countries Terminated
Terminated Phase 2 Est. completion 29 November 2024
🇦🇺 AU🇳🇿 NZ🇺🇸 US

Who might be able to join this trial: - You have previously been diagnosed with celiac disease, confirmed through a gut tissue sample (biopsy) and a positive blood test for celiac disease - You carry a specific gene variant called HLA-DQ2.5 (a genetic marker linked to celiac disease) - You have been following a strict...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02061306 · Massachusetts General Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇮🇹 IT🇺🇸 US

Who might be able to join this trial: - The baby must be a newborn or infant under 6 months old who has not yet started eating solid foods (only breast milk or formula). - The baby must have a close family member (such as a parent or sibling) who has been diagnosed with celiac disease confirmed by a biopsy. Who may no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03024775 · University of Palermo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2024
🇮🇹 IT

**Who might be able to join this trial:** - Your blood tests for certain antibodies related to celiac disease (anti-tissue transglutaminase and antiendomysium antibodies) have come back negative - A gut examination has shown that the lining of your small intestine is normal, with no damage to the tiny finger-like stru...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04219813 · University of Palermo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

Who might be able to join this trial: - You have been diagnosed with non-celiac gluten sensitivity or non-celiac wheat sensitivity and are currently following a gluten-free diet. Who may not be able to join: - You have been diagnosed with celiac disease. - You have a wheat or gluten allergy that involves your immune s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04280510 · Institut National de la Santé Et de la Recherche Médicale, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 February 2030
🇫🇷 FR

Who might be able to join this trial: - You are 18 years old or older - You are covered by social insurance (such as a health insurance or social security system) - You are able and willing to sign a consent form agreeing to take part in the trial Who may not be able to join: - You are currently pregnant - You are und...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04403074 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 October 2029
🇺🇸 US

Who might be able to join this trial: - You are 18 years of age or older - You have been referred to receive treatment for pain caused by chronic pancreatitis (long-term inflammation of the pancreas) Who may not be able to join: - You are under 18 years of age - You have not been diagnosed with chronic pancreatitis (l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04477928 · Sanford Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2031
🇺🇸 US

**Who might be able to join this trial:** - Newborn babies born at 36 weeks or later at a Sanford Health Hospital, whose mother is 18 or older and agreed to participate before active labor began, and who will have regular check-ups at a Sanford Clinic - Children under 6 years old who get their regular healthcare at a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04951804 · Centre hospitalier de l'Université de Montréal (CHUM) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇨🇦 CA

**Who might be able to join this trial:** - You have a pancreatic mass that looks like it could be cancer, or you have been diagnosed with pancreatic cancer in a specific part of the pancreas (the middle or left-side portion) - You have some level of abdominal or back pain that may be related to the mass - Your pain s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05209568 · Boston Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇺🇸 US

**Who might be able to join this trial:** - You have been following a gluten-free diet for at least 4 weeks - You are willing to eat gluten as part of the research - (For the celiac disease group only) Your celiac disease has been confirmed through a blood test and/or a tissue sample (biopsy) **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05236686 · Shanghai Gynecologic Oncology Group Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been diagnosed with stage III or IV ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has been confirmed by a pathology test, OR you have one of these cancers that has come back and is still responding to p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05468580 · Medisch Spectrum Twente Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇳🇱 NL

**Who might be able to join this trial:** - You have been diagnosed with Median Arcuate Ligament Syndrome (MALS) after being reviewed by a specialist team (including a vascular surgeon, stomach/gut doctor, and imaging specialist) at one of two Dutch expert centres. - You experience pain after eating, plus at least two...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05530070 · University of Pecs Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇭🇺 HU

**Who might be able to join this trial:** - You must be 18 years of age or older. - You must have a medical reason that already requires a blood draw. - You must be willing to sign a consent form agreeing to take part. - If you have celiac disease, your diagnosis must have been confirmed following current medical guide...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05576038 · McMaster University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2025
🇨🇦 CA

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been diagnosed with celiac disease, confirmed by both a positive intestinal biopsy and a positive blood test (anti-tTG IgA) - You still have ongoing celiac disease symptoms (scoring above 40 on a celiac symptom questionnaire) eve...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05597904 · Tampere University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇫🇮 FI

**Who might be able to join this trial:** - (Groups 1 and 2) You have been diagnosed with coeliac disease or dermatitis herpetiformis (a skin condition linked to gluten sensitivity). - (Group 3) You are a friend or non-related family member of someone who has been diagnosed with coeliac disease or dermatitis herpetifor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05633706 · Nimble Science Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 June 2025
🇨🇦 CA

**Who might be able to join this trial:** - You are between 18 and 80 years old. - For the **healthy/control group**: You have never been told by a doctor that you have Celiac Disease, Ulcerative Colitis, Crohn's disease, Irritable Bowel Syndrome (IBS), Functional Dyspepsia, or Type 2 Diabetes. - For the **disease gro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05644782 · University of Palermo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇮🇹 IT

**Who might be able to join this trial:** - You are between 18 and 65 years old - You have not used any systemic (whole-body) treatments for psoriasis for at least 3 months before joining the study - Your blood tests show negative results for certain antibodies related to coeliac disease (confirm with trial site) - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05680012 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** This trial has three separate groups, each with different requirements: **Gluten Challenge Group (people with celiac disease who eat gluten-free):** - You are between 18 and 75 years old - You were diagnosed with celiac disease by an intestinal biopsy at least 12 months ago -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05894746 · Göteborg University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇸🇪 SE

Who might be able to join this trial: - No specific requirements are listed for who can join (confirm with trial site) Who may not be able to join: - People who have been diagnosed with celiac disease (a condition where the immune system reacts to gluten) are not eligible Important: Always verify eligibility with the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05983978 · Instituto de Investigación Hospital Universitario La Paz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇪🇸 ES

Who might be able to join this trial: - People who are currently eating a diet that contains gluten, have a blood test showing raised levels of a celiac disease antibody (called TGt-IgA) above the normal range, and have had an intestinal biopsy confirming celiac disease. - People whose intestinal biopsy results show a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06059716 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 75 years old (any gender) - You have been diagnosed with celiac disease confirmed by a blood test and a small bowel tissue sample (biopsy) showing a specific level of intestinal damage - Your celiac disease diagnosis was made within 4 months of your first s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06160323 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
Hong Kong

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with pancreatic cancer that cannot be removed by surgery - You have ongoing tumor-related pain in the central abdomen that is constant and has no other clear cause, rated at least 3 out of 10 on a pain scale - You are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06191432 · University of Palermo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇮🇹 IT

Who might be able to join this trial: - You are between 18 and 65 years old. - Your blood tests show no signs of celiac disease-related antibodies (specific proteins the immune system makes in response to gluten). - You do not have damage to the lining of your small intestine (confirm with trial site), especially if yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06310291 · Barinthus Biotherapeutics Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with celiac disease, confirmed by both a blood test and a small bowel (intestinal) biopsy - You carry a specific gene type called HLA-DQ2.5, which is linked to celiac disease (confirm with trial site) - You are currently following a strict gluten-free...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06338891 · University of Palermo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2024
🇮🇹 IT

Who might be able to join this trial: - You are between 6 months and 80 years old and have been diagnosed with Familial Mediterranean Fever (FMF) based on recognised medical classification guidelines. - You are able to understand and fill out questionnaires on your own, or, if you are a child, a parent or guardian can...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06356220 · Boston Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: - You are between 2 and 18 years old and have recently been diagnosed with celiac disease. Who may not be able to join: - You are allergic to fewer than 3 of the top 8 most common food allergens (such as milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, or soybeans) (confirm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06364735 · ASST Fatebenefratelli Sacco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇮🇹 IT

**Who might be able to join this trial:** - You were diagnosed with celiac disease at the V. Buzzi Children's Hospital in Milan between January 2011 and December 2019 (dates within that range, not including January 2010 or December 2020 themselves) - Your diagnosis was made following recognized European guidelines for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06500754 · Hospital Mutua de Terrassa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇪🇸 ES

**Who might be able to join this trial:** - You were 18 years old or older when you were diagnosed with coeliac disease - You have been diagnosed with coeliac disease confirmed by intestinal damage (villous atrophy), a positive blood test, and you improved both in symptoms and blood test results after starting a gluten...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06568263 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2025
🇳🇴 NO

Who might be able to join this trial: - You are currently eating a regular, normal diet (not a special or restricted diet) Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Important: Always verify eligibility with the trial site directly before ap...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06710067 · Luventix, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇺🇸 US

Who might be able to join this trial: - You must be 18 years old or older when you sign up for the study. - You must be able and willing to provide a single urine sample and follow all study procedures. - You must be able to understand what the study involves, agree to take part, and be willing to sign a form allowing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06793527 · Jagiellonian University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇱 PL

Who might be able to join this trial: - You are 18 years of age or older and have had weight-loss (bariatric) surgery performed using a keyhole (laparoscopic) technique - You are able and willing to sign an agreement to take part in the study Who may not be able to join: - You have a history of allergic reactions to m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06849622 · Meyer Children's Hospital IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇮🇹 IT

Who might be able to join this trial: - Children between 2 and 13 years old - Children who have been officially diagnosed with either type 1 diabetes or celiac disease, OR children who do not have type 1 diabetes, celiac disease, or certain related antibodies in their blood - A parent or guardian has given their writte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07039773 · Oslo University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇳🇴 NO

**Who might be able to join this trial:** - Your body weight is in a healthy range for your height (specifically, your BMI is between 18 and 33) - You are willing to follow the study procedures and have signed a written consent form agreeing to take part - You were diagnosed with coeliac disease as a child, confirmed b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07069127 · University of Pavia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

**Who might be able to join this trial:** - You must be 18 years old or older with a confirmed diagnosis of celiac disease - You must have visible defects in your tooth enamel, such as weak or damaged enamel - You must have active tooth decay (cavities) - You must have reported experiencing sensitive teeth (pain or dis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07070596 · Hospital Mutua de Terrassa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇪🇸 ES

Who might be able to join this trial: - You are currently going through testing or assessment to find out whether you have celiac disease Who may not be able to join: - You are not willing or able to sign the consent form agreeing to take part in the trial Important: Always verify eligibility with the trial site dire...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07128966 · Joined Bio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2035
🇺🇸 US

Who might be able to join this trial: - You are an adult, which in most US states means aged 18 to 90 (aged 19–90 if you live in Alabama or Nebraska; aged 21–90 if you live in Mississippi or Puerto Rico). - You have read and signed a consent form agreeing to take part in the study, or if you have difficulty making deci...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07142122 · Fujian Cancer Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been diagnosed with a specific type of stomach cancer (gastric adenocarcinoma) or cancer at the junction where the esophagus meets the stomach, confirmed by a tissue biopsy - Your cancer is located in the upper part of the stoma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07172555 · Sheffield Teaching Hospitals NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2027
🇬🇧 GB

Who might be able to join this trial: - You are 18 years old or older - You have been diagnosed with coeliac disease, confirmed by a blood test or a biopsy (a small tissue sample taken by a doctor) Who may not be able to join: - You are under 18 years old - You are unable to give written consent to take part in the tr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07298343 · Dr. Falk Pharma GmbH Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2027
🇩🇪 DE

**Who might be able to join this trial:** - You are willing and able to sign a consent form agreeing to take part in the trial - You are a man or woman aged between 18 and 80 years old (inclusive) - You were diagnosed with celiac disease confirmed by a biopsy, or — if biopsy records are unavailable — you had a specific...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07326137 · Tongji Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 June 2028
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with advanced cancer of the bile ducts, gallbladder, or pancreas, confirmed by a laboratory test on a tissue sample. - You have ongoing cancer-related pain that scores 4 or higher on a pain scale of 0–10, has lasted more than one week, and your doctors...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07360106 · Sheffield Teaching Hospitals NHS Foundation Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇬🇧 GB

Who might be able to join this trial: - You are an adult between 18 and 65 years old who has been diagnosed with coeliac disease confirmed by a biopsy (a small tissue sample test) - A recent gut biopsy taken within the last 12 months shows that your coeliac disease is in remission (the gut lining has healed) - You have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07362654 · Fundación Pública Andaluza para la Investigación de Málaga en Biomedic... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇪🇸 ES

**Who might be able to join this trial:** - Your child is between 8 and 14 years old at the time of joining the study - Your child has been diagnosed with celiac disease following recognised diagnostic guidelines (ESPGHAN 2020 criteria) - Your child has been strictly following a gluten-free diet for at least 18 months...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07377565 · Nielsen Fernandez-Becker Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 75 years old - You are scheduled to have a camera examination of your throat, stomach, and upper small intestine (a scope procedure) because doctors suspect you may have celiac disease - Your body weight falls within a healthy-to-moderate range for you...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07387185 · Istituti Clinici Scientifici Maugeri SpA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇮🇹 IT

Who might be able to join this trial: - You must be 18 years old or older. - You must be scheduled to have a procedure to look inside your small bowel, either using a tiny swallowed camera (capsule endoscopy) or a flexible tube with a camera (endoscopy). Who may not be able to join: - You may not be able to join if yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07556328 · Tampere University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2035
🇫🇮 FI

Who might be able to join this trial: - You must be 18 years old or older - You are already scheduled to have a camera examination of your upper digestive system (a procedure where a thin tube with a camera is passed through your mouth to look at your stomach and small intestine) - You are willing and able to sign a co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07563582 · Istituto Giannina Gaslini Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇮🇹 IT

**Who might be able to join this trial:** - You have been diagnosed with celiac disease following current European guidelines, either based on symptoms or a tissue biopsy, and have been found to have low iron levels or iron-deficiency anemia. - You were between 8 and 18 years old (inclusive) when you were diagnosed wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07585669 · University of Chile Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2026
🇨🇱 CL

**Who might be able to join this trial:** - You are between 18 and 65 years old - You have recently been diagnosed with celiac disease, confirmed through blood tests and a small bowel tissue sample (biopsy) - You have not yet started following a gluten-free diet - You are willing to follow a supervised gluten-free diet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07716488 · Alexandra Miriam Kiess Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇩🇪 DE

Who might be able to join this trial: - Children and teenagers between the ages of 5 and 18 who are receiving ongoing treatment at the UKJ (University Hospital Jena) for a long-term health condition, such as a heart defect present from birth, inflammatory bowel disease, celiac disease, or a rheumatic disease Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Coeliac Disease. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

Coeliac Australia is the national body for people with coeliac disease.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.